var title_f2_62_3040="Color Doppler severe TR";
var content_f2_62_3040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Color flow Doppler in severe tricuspid regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 308px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The color flow Doppler obtained from the apical four chamber view shows that the tricuspid regurgitation (TR) jet has a large PISA and broad vena contracta (A to B), suggesting that the TR is severe.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; RA: right atrium.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3040=[""].join("\n");
var outline_f2_62_3040=null;
var title_f2_62_3041="Alogliptin and pioglitazone: Drug information";
var content_f2_62_3041=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Alogliptin and pioglitazone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F16057103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F16057106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidiabetic Agent, Dipeptidyl Peptidase IV (DPP-IV) Inhibitor;",
"     </li>",
"     <li>",
"      Antidiabetic Agent, Thiazolidinedione",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F16057102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oseni&trade;: FDA approved January 2013; anticipated availability is the summer of 2013. Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F16057560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as an adjunct to diet and exercise in patients not adequately controlled on alogliptin or pioglitazone monotherapy",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87806 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.211.0.116-30B47D18B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3041=[""].join("\n");
var outline_f2_62_3041=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16057103\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16057106\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16057102\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16057560\">",
"      Use",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/87806\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/87806|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_62_3042="EUS panc pseudocyst";
var content_f2_62_3042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Endoscopic ultrasound (EUS) image of a pancreatic pseudocyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Raj J Shah, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3042=[""].join("\n");
var outline_f2_62_3042=null;
var title_f2_62_3043="Common bile duct stone on ERCP";
var content_f2_62_3043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59987&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59987&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Common bile duct stone on ERCP",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 441px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cholangiogram showing large (2 cm) common bile duct stone (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Martin L. Freeman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3043=[""].join("\n");
var outline_f2_62_3043=null;
var title_f2_62_3044="Hindfoot forefoot mobility test";
var content_f2_62_3044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68127&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68127&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 475px\">",
"   <div class=\"ttl\">",
"    Hindfoot and forefoot mobility testing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 455px; height: 435px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B) Note the interdependence between the hindfoot and the forefoot, the heel, first metatarsal head, and fifth metatarsal head have a tripod relationship. When the first metatarsal is pronated, the forefoot supinates to get the first and fifth metatarsal heads flat on the floor and the hindfoot inverts. (C, D) In the Coleman standing lateral block test, the heel and lateral border of the foot are on a 1.5-inch block, and the first and second metatarsals dangle at the edge of the block into pronation. When mobility is present between the hindfoot and the forefoot, the heel moves to its normal position of 5 degrees eversion. (E, F) In the Carroll test, the patient stands with his hindfoot on a 2 or 3-inch wooden block (or a hard book) and the forefoot dangles free at the edge of the block. When flexibility between the hindfoot and forefoot is normal, the heel everts to normal position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tachdjian, MO. Clinical pediatric orthopedics: the art of diagnosis and principles of management. Appleton &amp; Lange, Stamford, CT 1997. p.52. Copyright &copy; 1997 McGraw-Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3044=[""].join("\n");
var outline_f2_62_3044=null;
var title_f2_62_3045="Breast MRI of breast cancer recurrence";
var content_f2_62_3045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F74918&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F74918&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Breast MRI of breast cancer recurrence",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 658px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Breast MRI can be used to differentiate postoperative scarring from breast cancer recurrence. This series depicts a patient with a prior history of right lumpectomy for invasive carcinoma who presented for annual mammography.",
"    <br>",
"     (A) The mammogram shows a new irregular mass posterior to the lumpectomy bed in the posterior central right breast (arrow).",
"     <br>",
"      (B) Sagital MRI images demonstrate a low signal mass in the posterior inferior right breast on the T2-weighted MRI image and on the pre-gadolinium enhanced T1-weighted image.",
"      <br>",
"       (C) Subtraction of the pre and post contrast sagittal T1-weighted images of the right breast shows an enhancing mass in the posterior central right breast confirming suspicion for recurrence. Biopsy revealed recurrent invasive ductal carcinoma.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3045=[""].join("\n");
var outline_f2_62_3045=null;
var title_f2_62_3046="Cardiovascular effects of hypothyroidism";
var content_f2_62_3046=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cardiovascular effects of hypothyroidism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/62/3046/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3046/contributors\">",
"     Irwin Klein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/62/3046/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3046/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/62/3046/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3046/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/62/3046/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothyroidism is characterized by a decrease in oxygen and substrate utilization by all the major organ systems of the body. As a result, the demands for cardiac output decrease; in addition, hypothyroidism directly alters cardiac function through changes in myocyte-specific gene expression [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1\">",
"     1",
"    </a>",
"    ]. This topic will review the cardiovascular manifestations of overt hypothyroidism. Other symptoms of hypothyroidism and cardiovascular manifestations of subclinical hypothyroidism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"     \"Clinical manifestations of hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/48/3850?source=see_link\">",
"     \"Subclinical hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major cardiovascular changes that occur in hypothyroidism include a decrease in cardiac output and cardiac contractility, a reduction in heart rate, and an increase in peripheral vascular resistance (",
"    <a class=\"graphic graphic_figure graphicRef85918 \" href=\"UTD.htm?33/21/34135\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. There are also significant changes in modifiable atherosclerotic risk factors, including hypercholesterolemia, diastolic hypertension, carotid intimal media thickness, and endothelial derived relaxation factor (nitric oxide), which accompany overt hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cardiac contractility",
"    </span>",
"    &nbsp;&mdash;&nbsp;All measures of left ventricular performance are impaired in both short- and long-term hypothyroidism, leading to a reduction in cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. There is also a decrease in the rate of ventricular diastolic relaxation; as a result, compliance and diastolic filling are impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reduced ventricular performance is probably multifactorial. Possible mechanisms include increases in afterload and changes in expression of the genes for myocardial calcium regulatory proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. Several enzymes involved in regulating calcium fluxes in the heart are controlled by thyroid hormone, including the calcium-dependent adenosine triphosphatase and phospholamban [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. Hypothyroidism-dependent decreases in the expression and activity of these enzymes could potentially impair systolic performance and diastolic relaxation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/6\">",
"     6",
"    </a>",
"    ]. Beta adrenergic receptor expression is also decreased, resulting in a blunted response to catecholamine mediated increases in inotropy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Vascular resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone relaxes vascular smooth muscle cells, thereby reducing peripheral vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/3\">",
"     3",
"    </a>",
"    ]. Conversely, hypothyroidism causes a decrease in the release of endothelial-derived relaxation factor, which in turn promotes contraction of these cells thereby increasing peripheral vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/2\">",
"     2",
"    </a>",
"    ]. This change results in reductions in cardiac output (in part because the heart cannot increase contractility to compensate) and tissue perfusion. Tissue oxygen utilization is also decreased; thus, arteriovenous (A-V) oxygen extraction is not different from that in normal subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms and signs of cardiovascular dysfunction are not common or prominent in patients with hypothyroidism. Those that do occur include (",
"    <a class=\"graphic graphic_table graphicRef68946 \" href=\"UTD.htm?22/61/23515\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1,3,6\">",
"     1,3,6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Exertional dyspnea and exercise intolerance, although these symptoms are probably due to skeletal muscle dysfunction",
"     </li>",
"     <li>",
"      Bradycardia",
"     </li>",
"     <li>",
"      Hypertension resulting from the increase in vascular resistance and the fall in EDRF [",
"      <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cardiac dysfunction with poor contractility, dilatation or pericardial effusion",
"     </li>",
"     <li>",
"      Edema, often nonpitting",
"     </li>",
"     <li>",
"      Pericardial effusions, which occur in approximately 25 percent of patients and may be quite large",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Rhythm disturbances",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to a slow pulse rate, hypothyroid patients may have ventricular premature beats and rarely ventricular tachycardia with a long QT interval (torsade de pointes) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .) This can be especially problematic in patients with underlying ischemic heart disease or known ventricular arrhythmias. Treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    can produce hypothyroidism and in turn further predispose the ischemic heart to ventricular arrhythmias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/30/25065?source=see_link&amp;anchor=H10#H10\">",
"     \"Amiodarone and thyroid dysfunction\", section on 'Hypothyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone plays a role in blood pressure homeostasis. In patients who had undergone total thyroidectomy for thyroid cancer, withdrawal of thyroxine for six weeks results in an increase in serum norepinephrine and aldosterone concentrations, and an increase in blood pressure with a greater rise in diastolic pressure",
"    <span class=\"nowrap\">",
"     (126/85",
"    </span>",
"    compared with",
"    <span class=\"nowrap\">",
"     120/76",
"    </span>",
"    mmHg at baseline) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/9\">",
"     9",
"    </a>",
"    ]. Diastolic blood pressure may vary directly with serum TSH levels over the entire spectrum of thyroid disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1,9\">",
"     1,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 20 to 40 percent of hypothyroid patients have hypertension, even though cardiac output is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. The hypertension is primarily diastolic and the pulse pressure is diminished. In hypertensive hypothyroid patients, the serum levels of renin are low and there is an increased prevalence of salt sensitivity confirming the importance of the increase in systemic vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. Among large groups of patients with hypertension, however, hypothyroidism is a contributory factor in only a small percentage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cardiac dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The upstroke of the pulse may be slow and the left ventricular apical impulse weak [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/5\">",
"     5",
"    </a>",
"    ]. The heart may be enlarged, and the heart sounds distant. These findings, plus dyspnea, exercise intolerance, and edema, may make it seem as if the patient has congestive heart failure. However, heart failure due solely to hypothyroidism is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrocardiograms may show low voltage and nonspecific ST segment and Q wave changes. Occasionally, large pericardial effusion can occur, characterized by a high protein and cholesterol content (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65059 \" href=\"UTD.htm?40/42/41632\">",
"     image 1",
"    </a>",
"    ). These are rarely hemodynamically important and should be managed with thyroid hormone replacement, not by needle or surgical drainage. The latter can lead to hemodynamic worsening [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Coronary artery disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with angina pectoris probably have symptoms less often if they become hypothyroid, because they are less active and peripheral oxygen demands decrease. The occurrence of anginal-like pain in some hypothyroid patients and the frequent occurrence of hypercholesterolemia diastolic hypertension, and elevated homocysteine levels have led to suggestions that hypothyroidism is associated with accelerated coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potential mechanisms in addition to lipid abnormalities and diastolic hypertension include elevated concentrations of C-reactive protein and endothelial dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/2,12,13\">",
"     2,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential risk of coronary artery disease in subclinical hypothyroidism is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/48/3850?source=see_link\">",
"     \"Subclinical hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periorbital edema and nonpitting edema of the hands and feet are characteristic features of hypothyroidism, albeit rare today. Nonpitting edema is due to interstitial accumulation of glycosaminoglycans (hyaluronic acid and chondroitin sulfate), with associated extravascular water retention at the same time that plasma volume is decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/3,4,14\">",
"     3,4,14",
"    </a>",
"    ]. Some patients have pitting edema of the feet and legs, probably secondary to an increase in albumin content of the interstitial fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/15\">",
"     15",
"    </a>",
"    ]. Ascites, pleural, and scrotal effusions may also be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Lipids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyslipidemia is common in hypothyroidism. The usual findings are high serum total and low-density-lipoprotein (LDL) cholesterol concentrations. Some patients have high serum very-low-density-lipoprotein (VLDL) cholesterol concentrations, and a few have hypertriglyceridemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28550?source=see_link\">",
"     \"Lipid abnormalities in thyroid disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The spectrum and frequency of lipid abnormalities that can occur was illustrated in a report from the Mayo Clinic which evaluated 295 patients with hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/16\">",
"     16",
"    </a>",
"    ]. Hypercholesterolemia was present in 56 percent of the patients, hypercholesterolemia and hypertriglyceridemia in 34 percent, and hypertriglyceridemia in 1.5 percent; only 8.5 percent had a normal lipid profile. The changes in serum LDL cholesterol have been related to reduced expression of LDL receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/17\">",
"     17",
"    </a>",
"    ] and decreased hepatic and biliary LDL cholesterol clearance.",
"   </p>",
"   <p>",
"    Another study evaluated the prevalence of hypothyroidism in patients referred for hyperlipidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/18\">",
"     18",
"    </a>",
"    ]. Among 1509 consecutive patients, hypothyroidism was present in 4.2 percent, approximately twice the incidence in the general population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Homocysteine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with hypothyroidism have high serum homocysteine concentrations, which fall toward if not to normal with thyroxine (T4) therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Creatine kinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many hypothyroid patients have high serum creatine (CK) kinase concentrations. The isoenzyme distribution is almost completely MM, with less than 4 percent constituting MB, indicating skeletal muscle, not myocardial, origin [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/20\">",
"     20",
"    </a>",
"    ]. However, as many as 14 percent of patients with hypothyroidism have a raised serum concentration of CK-MB, which can be confusing in the evaluation of chest pain. This problem is obviated by measurement of serum troponin I, which is normal in hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .) In addition, hypothyroid patients receiving statin therapy for the treatment of hypercholesterolemia may be at increased risk for both myopathy and elevated CK levels [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The changes in cardiovascular function in hypothyroidism respond to replacement therapy with T4 (",
"    <a class=\"graphic graphic_figure graphicRef63451 \" href=\"UTD.htm?41/19/42301\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/5\">",
"     5",
"    </a>",
"    ]. In older patients or those with a history of angina, it is wise to begin therapy with a low dose of T4, as an example 12.5 or 25 mcg daily, because of the possibility of inducing an arrhythmia or an exacerbation of angina. T4 equilibrates slowly and its onset of action is slow, so that the dose should not be increased for four to six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    .) The treatment of myxedema coma is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8566?source=see_link\">",
"     \"Myxedema coma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A 1961 report remains the largest and best study of the effects of beginning thyroid hormone on chest pain in patients with hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/22\">",
"     22",
"    </a>",
"    ]. Among 1503 hypothyroid patients, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      55 had angina before thyroid hormone replacement therapy. During therapy, 21 improved, 25 had no change, and 9 had more angina.",
"     </li>",
"     <li>",
"      35 patients developed new angina during therapy, six during the first month, six during the first year, and 23 after one year.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, angina may improve, and it does not often appear during T4 replacement therapy.",
"   </p>",
"   <p>",
"    In patients with overt hypothyroidism, T4 therapy for several months raises the 24-hour heart rate by approximately 10 percent. It usually does not increase the frequency of premature atrial beats (22 of 25 patients had no increase in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/23\">",
"     23",
"    </a>",
"    ]) or of premature ventricular beats. TSH measurements should guide treatment to assure precise replacement into the optimal euthyroid range.",
"   </p>",
"   <p>",
"    The clearance of many drugs, including anticoagulant drugs, is decreased in hypothyroidism. In patients being treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    anticoagulation, the dose required to maintain a therapeutic prothrombin time increases during hypothyroidism, and this increase is reversed with restoration of a normal TSH [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long-term cardiovascular outcomes of patients treated for hypothyroidism are unclear. A population based study assessed mortality and vascular outcomes among 15,889 treated individuals and 524,152 subjects in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/24\">",
"     24",
"    </a>",
"    ]. Excess cardiovascular morbidity from arrhythmias and non-fatal ischemic heart and cerebrovascular disease was observed among those treated for hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3046/abstract/24\">",
"     24",
"    </a>",
"    ]. However, there was no increase in all-cause mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major cardiovascular changes that occur in hypothyroidism include a decrease in cardiac output and cardiac contractility, a reduction in heart rate, and an increase in peripheral vascular resistance. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms of cardiovascular dysfunction are not common or prominent in patients with hypothyroidism. They may include exertional dyspnea, exercise intolerance, and edema. Findings on physical examination may include bradycardia, hypertension, nonpitting edema, and pleural or pericardial effusion (",
"      <a class=\"graphic graphic_table graphicRef68946 \" href=\"UTD.htm?22/61/23515\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dyslipidemia is common in hypothyroidism. The usual findings are high serum total and low-density-lipoprotein (LDL) cholesterol concentrations. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Lipids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The changes in cardiovascular function in hypothyroidism respond to replacement therapy with T4 (",
"      <a class=\"graphic graphic_figure graphicRef63451 \" href=\"UTD.htm?41/19/42301\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/1\">",
"      Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116:1725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/2\">",
"      Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003; 88:3731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/3\">",
"      Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/4\">",
"      GRAETTINGER JS, MUENSTER JJ, CHECCHIA CS, et al. A correlation of clinical and hemodynamic studies in patients with hypothyroidism. J Clin Invest 1958; 37:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/5\">",
"      Crowley WF Jr, Ridgway EC, Bough EW, et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med 1977; 296:1.",
"     </a>",
"    </li>",
"    <li>",
"     Klein I. Endocrine disorders and cardiovascular disease. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th, Libby P, Bonow RO, Mann DL, Zipes DP (Eds), Saunders Elsevier, Philadelphia 2008. p.2033.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/7\">",
"      Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 2002; 12:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/8\">",
"      Fredlund BO, Olsson SB. Long QT interval and ventricular tachycardia of \"torsade de pointe\" type in hypothyroidism. Acta Med Scand 1983; 213:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/9\">",
"      Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab 2002; 87:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/10\">",
"      Gumieniak O, Perlstein TS, Hopkins PN, et al. Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab 2004; 89:3455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/11\">",
"      Kabadi UM, Kumar SP. Pericardial effusion in primary hypothyroidism. Am Heart J 1990; 120:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/12\">",
"      Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/13\">",
"      Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004; 24:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/14\">",
"      Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/15\">",
"      Parving HH, Hansen JM, Nielsen SL, et al. Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med 1979; 301:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/16\">",
"      O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993; 68:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/17\">",
"      Thompson GR, Soutar AK, Spengel FA, et al. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci U S A 1981; 78:2591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/18\">",
"      Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995; 155:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/19\">",
"      Catargi B, Parrot-Roulaud F, Cochet C, et al. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid 1999; 9:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/20\">",
"      Klein I, Mantell P, Parker M, Levey GS. Resolution of abnormal muscle enzyme studies in hypothyroidism. Am J Med Sci 1980; 279:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/21\">",
"      Rush, J, Danzi, S, Klein, I. Role of thyroid disease in the development of statin-induced myopathy. Endocrinologist 2006; 16:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/22\">",
"      KEATING FR Jr, PARKIN TW, SELBY JB, DICKINSON LS. Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 1961; 3:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/23\">",
"      Polikar R, Feld GK, Dittrich HC, et al. Effect of thyroid replacement therapy on the frequency of benign atrial and ventricular arrhythmias. J Am Coll Cardiol 1989; 14:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3046/abstract/24\">",
"      Flynn RW, Macdonald TM, Jung RT, et al. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 2006; 91:2159.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7852 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-D34A3220F9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3046=[""].join("\n");
var outline_f2_62_3046=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cardiac contractility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Vascular resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Rhythm disturbances",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Blood pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cardiac dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Lipids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Homocysteine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Creatine kinase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7852\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7852|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/42/41632\" title=\"diagnostic image 1\">",
"      Pericardial effusion due to hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7852|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/21/34135\" title=\"figure 1\">",
"      Thyroid hormone changes cardiac output",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/19/42301\" title=\"figure 2\">",
"      T4 replacement and the heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7852|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/61/23515\" title=\"table 1\">",
"      Heart in hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/30/25065?source=related_link\">",
"      Amiodarone and thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28550?source=related_link\">",
"      Lipid abnormalities in thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8566?source=related_link\">",
"      Myxedema coma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/48/3850?source=related_link\">",
"      Subclinical hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_62_3047="Uric acid nephrolithiasis";
var content_f2_62_3047=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Uric acid nephrolithiasis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/62/3047/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3047/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3047/contributors\">",
"     Michael A Becker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/62/3047/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3047/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/62/3047/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/62/3047/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/62/3047/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid stones account for 5 to 10 percent of urinary tract stones in the United States and Europe. In contrast, they comprise 40 percent or more of stones in areas with hot, arid climates in which the tendency to a low urine volume and acid urine pH promote uric acid precipitation. The risk of both uric acid and calcium stones is also increased in patients with gout. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical manifestations and diagnosis of gout\", section on 'Nephrolithiasis'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H12509811\">",
"     'Gout'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link&amp;anchor=H11#H11\">",
"     \"Risk factors for calcium stones in adults\", section on 'Hyperuricosuria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link&amp;anchor=H14#H14\">",
"     \"Risk factors for calcium stones in adults\", section on 'Other factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues related to uric acid stone disease will be reviewed here. The general approach to the patient with nephrolithiasis and other management issues related to hyperuricemia and gout are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=see_link\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29033?source=see_link\">",
"     \"Evaluation of the adult patient with established nephrolithiasis and treatment if stone composition is unknown\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gout\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/24/1416?source=see_link\">",
"     \"Asymptomatic hyperuricemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H327386715\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two major factors that promote uric acid precipitation are a high urine uric acid concentration and an acid urine pH, which drives the following reaction toward the right, converting the relatively soluble urate salt into insoluble uric acid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;H",
"    <sup>",
"     +",
"    </sup>",
"    &nbsp; + &nbsp; Urate",
"    <sup>",
"     -",
"    </sup>",
"    &nbsp; &nbsp;&harr; &nbsp; &nbsp;Uric acid",
"   </p>",
"   <p>",
"    A low urine pH is the more significant of these two biochemical risk factors for the development of uric acid nephrolithiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/3-9\">",
"     3-9",
"    </a>",
"    ]. Uric acid solubility in the urine falls from approximately 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    at a urine pH of 7.0 (a setting in which 95 percent of uric acid is present as the more soluble urate anion) to 15",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.09",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    at a urine pH of 5.0 (a setting in which most of the uric acid is the less soluble, undissociated acid) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of a low urine pH was illustrated by the biochemical characterization of 341 uric acid stone formers from four studies. The mean urine pH in patients with uric acid nephrolithiasis was 5.4, and virtually all patients had a urine pH less than 6.0 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. By comparison, the mean urine pH among calcium stone formers was 6.1. Hyperuricosuria, which has been traditionally, although arbitrarily, defined as a 24-hour urine uric acid excretion of more than 750 mg (4.5 mmol) in women or more than 800 mg (4.8 mmol) in men, was uncommon in the patients with uric acid stones. Uric acid excretion was higher in patients who formed calcium stones, but the role of hyperuricosuria in calcium stone formation is unproven. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link&amp;anchor=H11#H11\">",
"     \"Risk factors for calcium stones in adults\", section on 'Hyperuricosuria'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    A low urine pH",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    high uric acid concentration can also explain the association between other disorders and uric acid stone formation. Examples include chronically increased uric acid production, as in myeloproliferative diseases such as polycythemia vera (",
"    <a class=\"graphic graphic_table graphicRef80891 \" href=\"UTD.htm?5/49/5916\">",
"     table 1",
"    </a>",
"    ), and when the urine pH is acid and the urine volume is relatively low as with chronic diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/1,11\">",
"     1,11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Predisposing clinical conditions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREDISPOSING CLINICAL CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid nephrolithiasis primarily occurs in patients with no obvious abnormality in uric acid metabolism. Patients who form uric acid stones often possess a combination of biochemical features that are similar to those seen in patients with primary gout who underexcrete uric acid. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=see_link&amp;anchor=H6#H6\">",
"     \"Uric acid balance\", section on 'Hyperuricemia'",
"    </a>",
"    .) However, there are a number of conditions other than gout that increase the risk of uric acid stone formation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12509811\">",
"    <span class=\"h2\">",
"     Gout",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid stone disease can occur at any time in the course of gout, antedating gouty arthritis in up to 40 percent of patients with primary gout. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical manifestations and diagnosis of gout\", section on 'Nephrolithiasis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with gout and clinical stone disease, as in other uric acid stone formers, the primary predisposing factor is a persistently acid urine (urine pH below 5.0 to 5.5), which appears to reflect a relative impairment in ammonium excretion in favor of titratable acid [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The low urine pH creates an environment in which uric acid is more likely to precipitate, even though total 24-hour excretion may be normal [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/1\">",
"     1",
"    </a>",
"    ]. A low urine pH is also seen in patients with gout who overproduce uric acid and therefore have hyperuricosuria; the combination of an acid urine and a high urine uric acid concentration leads to an increased risk of uric acid nephrolithiasis observed in this group. However, calcium oxalate stones are the most common type of stone formed by individuals with gout as they are in individuals without gout [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H327386715\">",
"     'Pathogenesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The prevalence of clinical stone disease of any type (ie, not limited to uric acid stones) in patients with gout was evaluated in two large cohort studies: a retrospective study from the National Health and Nutrition Examination Survey III (NHANES III), and a prospective report from the Health Professionals' Follow-Up Study [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The overall prevalence of stone disease was 14 and 15 percent, respectively, with an odds ratio after multivariable adjustment of 1.5 and 1.9, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H74756171\">",
"    <span class=\"h3\">",
"     Increased fractional excretion of uric acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uricosuric drugs used in the prevention of recurrent gout produce only a transient increase in urinary uric acid excretion, since the ensuing fall in the serum uric acid concentration results in the reestablishment of a new steady state in which uric acid production and excretion are equivalent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=see_link&amp;anchor=H838162389#H838162389\">",
"     \"General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)\", section on 'The steady state'",
"    </a>",
"    .) Thus, it is unlikely that uricosuric drugs increase the risk of uric acid stones. If there is a transient increase in risk after the initiation of therapy, there is no long-term increase in risk.",
"   </p>",
"   <p>",
"    The fractional excretion of uric acid is also increased in certain rare genetic mutations in renal urate transporters. However, several features of these disorders distinguish them from uricosuric drugs. In severe cases, the serum uric acid may fall close to zero, indicating a much more severe defect than seen with uricosuric drugs. Furthermore, some patients with these mutations have chronic hyperuricosuria. The reasons for this are not fully known, but it is possible that urate which is normally eliminated in the stool is diverted and eliminated in the urine (ie, less gastrointestinal clearance of the daily uric acid load in favor or more urinary clearance) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/15\">",
"     15",
"    </a>",
"    ]. These patients may have a persistent increase in uric acid stone formation in contrast to the transient increase with uricosuric drugs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7177?source=see_link&amp;anchor=H9#H9\">",
"     \"Hypouricemia: Causes and clinical significance\", section on 'Familial renal hypouricemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7177?source=see_link&amp;anchor=H559528#H559528\">",
"     \"Hypouricemia: Causes and clinical significance\", section on 'Uric acid stone formation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H74756126\">",
"    <span class=\"h2\">",
"     Uric acid overproduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid stones can form in conditions associated with chronically increased uric acid production other than gout (",
"    <a class=\"graphic graphic_table graphicRef80891 \" href=\"UTD.htm?5/49/5916\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12509827\">",
"    <span class=\"h2\">",
"     Chronic diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid stones can be seen in patients with chronic diarrheal states in which bicarbonate loss and volume depletion lead to a concentrated, acid urine [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/12\">",
"     12",
"    </a>",
"    ]. This is particularly true in patients who have undergone colonic resection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/16\">",
"     16",
"    </a>",
"    ]. The risk of calcium oxalate stones is also increased in patients with chronic diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12509834\">",
"    <span class=\"h2\">",
"     Diabetes mellitus and metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 2 diabetes mellitus and the metabolic syndrome are associated with an increased incidence of uric acid stones, possibly related to reduced ammoniagenesis and decreased urinary pH [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]. Why this occurs is not clear, but both diabetes and the metabolic syndrome are characterized by increased body weight, which is associated with both a more acid urine pH and increases in urinary uric acid excretion and supersaturation in proportion to the increase in body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with uric acid nephrolithiasis usually present with the acute onset of flank pain, and often a history of a predisposing underlying condition such as gout. Non-contrast-enhanced computerized tomography (CT) scan is the preferred radiologic test to establish the presence of a stone, but may be negative if a stone has passed. Plain x-ray is not helpful since uric acid stones are not radiopaque [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The type of stone is best determined by chemical analysis of a stone that has passed. There is some evidence suggesting that dual-energy CT scan can distinguish between different types of stones, including differentiating uric acid from calcium stones [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, 24-hour urine collection, which is a standard test in the evaluation of nephrolithiasis, does not typically reveal hyperuricosuria. A persistently acid urine pH is the primary risk factor in patients with normal urinary uric acid excretion. (See",
"    <a class=\"local\" href=\"#H327386715\">",
"     'Pathogenesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Most commercial laboratories offer testing of 24-hour urine samples to evaluate kidney stone risk. These laboratories will calculate the urinary supersaturation of uric acid, which is a helpful parameter to follow during treatment since it integrates urine volume, uric acid excretion, and pH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because hydration and medical therapy can lead to dissolution of uric acid stones, more invasive procedures (such as extracorporeal shock wave lithotripsy) are usually not required. The three treatments options for patients with uric acid nephrolithiasis include [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Alkalinization of the urine",
"     </li>",
"     <li>",
"      Increased fluid intake",
"     </li>",
"     <li>",
"      Reduction of uric acid generation with xanthine oxidase inhibitors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Urinary alkalinization and increased fluid intake should be prescribed to almost all patients with uric acid stones. Xanthine oxidase inhibitors are usually reserved for patients with a high uric acid excretion (greater than 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [6",
"    <span class=\"nowrap\">",
"     mmol/day])",
"    </span>",
"    who continue to have stones despite urinary alkalinization and a prescribed higher fluid intake. However, patients with uric acid stones who also have recurrent or tophaceous gouty arthritis should be treated with a xanthine oxidase inhibitor for long-term control of gouty manifestations, even though it may not be indicated in the prevention of kidney stones. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/26/36266?source=see_link\">",
"     \"Prevention of recurrent gout\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Urinary alkalinization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of increasing the urine pH on uric acid solubility can be appreciated from the Henderson-Hasselbalch equation for the relationship between soluble urate and insoluble uric acid, where 5.35 is functionally the pKa for this reaction under conditions existing in urine [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;pH &nbsp; = &nbsp; 5.35 &nbsp;+ &nbsp;log &nbsp;([urate] &nbsp;&divide; &nbsp;[uric acid])",
"   </p>",
"   <p>",
"    At a urine pH of 6.75, more than 90 percent of the total urinary uric acid will be the more soluble urate salt, thereby minimizing the risk of uric acid precipitation.",
"   </p>",
"   <p>",
"    There are no randomized trials that have evaluated the efficacy of urinary alkalinization on recurrence or dissolution of uric acid stones. However, alkalinization is associated with a remarkable reduction in recurrent stone episodes in observational studies. As an example, the mean rate of recurrent uric acid stones among 18 patients was reduced from 1.2 to 0.01 stones per patient per year with long-term treatment with potassium citrate [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/30\">",
"     30",
"    </a>",
"    ]. Alkalinization can also dissolve existing uric acid calculi, as demonstrated in eight patients with recurrent uric acid stones who underwent serial ultrasound examinations after initiating potassium citrate or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/35/7731?source=see_link\">",
"     potassium bicarbonate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alkalinization therapy should target a urine pH between 6.1 and 7.0. Achieving a urine pH higher than 7.0 will provide little if any further benefit on uric acid stone formation and may increase the risk of calcium phosphate stone formation. An alkaline urine pH may not need to be maintained at all times, since raising the urine pH to at least 6.5 once per day or every other day prevents uric acid stone formation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/35/7731?source=see_link\">",
"     potassium bicarbonate",
"    </a>",
"    or potassium citrate can be given, with the typical dose being 40 to 80",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/3,30\">",
"     3,30",
"    </a>",
"    ]. This regimen can both dissolve preexisting stones and prevent the formation of new stones. Alkalinization with potassium salts is preferable, since the sodium load with sodium citrate or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    may increase calcium excretion and promote the formation of calcium stones in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/30\">",
"     30",
"    </a>",
"    ]. Patients should be instructed to check their urine pH at home; this will help guide the amount of alkali required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link\">",
"     \"Risk factors for calcium stones in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14770579\">",
"    <span class=\"h2\">",
"     Increased fluid intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with uric acid stones (as with other types of stones) should be encouraged to drink enough fluids to achieve a 24-hour urine volume of at least two liters. The potential importance of increasing fluid intake was shown in a randomized trial of 199 patients with calcium stones [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/33\">",
"     33",
"    </a>",
"    ]. During five years of follow-up, the rate of recurrent stones was significantly lower in the patients who were counseled to increase their urine volume to at least two liters per day (12 versus 27 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Xanthine oxidase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    to lower uric acid production and excretion is generally reserved for patients who",
"    <strong>",
"     continue",
"    </strong>",
"    to form uric acid stones despite alkali therapy and increased fluid intake [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/3\">",
"     3",
"    </a>",
"    ]. This is most likely to be required in patients who excrete more than 1000 mg (5.4 mmol) of uric acid per day, but allopurinol is warranted even if urinary uric acid excretion is normal.",
"   </p>",
"   <p>",
"    There are no randomized trials that have evaluated the effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    on the risk of forming uric acid stones in patients with hyperuricosuria. The only randomized trial that tested allopurinol in patients with nephrolithiasis included 60 patients with calcium oxalate (not uric acid) stones and hyperuricosuria (which was defined as a 24 hour uric acid excretion of 800 mg or more in men and 750 mg or more in women) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/34\">",
"     34",
"    </a>",
"    ]. During approximately three years of follow-up, new clinical stone episodes were significantly less frequent in patients taking allopurinol compared with placebo (31 versus 58 percent).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29668?source=see_link\">",
"     Febuxostat",
"    </a>",
"    , a newer xanthine oxidase inhibitor, inhibits uric acid production and reduces uric acid excretion by 40 to 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/62/3047/abstract/35\">",
"     35",
"    </a>",
"    ]. However, data demonstrating a reduction in stone formation with febuxostat are lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/53/28499?source=see_link\">",
"       \"Patient information: Kidney stones in adults (Beyond the Basics)\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6582391\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uric acid stones account for 5 to 10 percent of all renal calculi in the United States and Europe; however, they comprise 40 percent or more of stones in areas with hot, arid climates. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important biochemical risk factor for uric acid nephrolithiasis is a persistently low urine pH. Hyperuricosuria is not always present in patients with pure uric acid stones. (See",
"      <a class=\"local\" href=\"#H327386715\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Low urine volume (with a high urine concentration of uric acid) and an acid urine pH drive the conversion of the relatively soluble urate salt into insoluble uric acid. (See",
"      <a class=\"local\" href=\"#H327386715\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common clinical conditions that increase the risk of uric acid stone formation include gout, chronic diarrhea, diabetes, and the metabolic syndrome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Predisposing clinical conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with uric acid nephrolithiasis usually present with the acute onset of flank pain, often in the setting of a known predisposing condition (such as gout). Non contrast-enhanced computerized tomography (CT) typically reveals the presence of a stone. Confirmation of the diagnosis is best made by chemical analysis of a stone that has been passed. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Invasive treatments may be needed for large and acutely symptomatic stones. However, for asymptomatic renal stones, non-invasive treatments should be attempted first since hydration and medical therapy can lead to dissolution of uric acid stones. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with uric acid nephrolithiasis, we recommend urinary alkalinization and an increased fluid intake (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Alkalinization is generally performed with potassium citrate or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/35/7731?source=see_link\">",
"       potassium bicarbonate",
"      </a>",
"      , and should target a urine pH between 6.1 and 7.0. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Urinary alkalinization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with uric acid stones should be encouraged to drink enough fluids to achieve a 24-hour urine volume of at least two liters. (See",
"      <a class=\"local\" href=\"#H14770579\">",
"       'Increased fluid intake'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients who",
"      <strong>",
"       continue",
"      </strong>",
"      to form uric acid stones despite urinary alkalinization and a higher fluid intake, we recommend treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Such patients usually have hyperuricosuria (greater than 1000",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      [6",
"      <span class=\"nowrap\">",
"       mmol/day])",
"      </span>",
"      but allopurinol is warranted even in patients with normal urinary acid excretion. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Xanthine oxidase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/1\">",
"      Coe FL. Uric acid and calcium oxalate nephrolithiasis. Kidney Int 1983; 24:392.",
"     </a>",
"    </li>",
"    <li>",
"     Perez-Ruiz, F, Hernando, I, Herrero-Beites, AM. Uricosuric therapy. In: Crystal-Induced Arthropathies, Wortmann, RL, Schumacher, HR, Jr, Becker, MA, Ryan, LM (Eds), New York, Taylor &amp; Francis Group, 2006. pp. 369-380.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/3\">",
"      Kenny JE, Goldfarb DS. Update on the pathophysiology and management of uric acid renal stones. Curr Rheumatol Rep 2010; 12:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/4\">",
"      Pak CY, Sakhaee K, Peterson RD, et al. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 2001; 60:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/5\">",
"      Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002; 62:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/6\">",
"      Negri AL, Spivacow R, Del Valle E, et al. Clinical and biochemical profile of patients with \"pure\" uric acid nephrolithiasis compared with \"pure\" calcium oxalate stone formers. Urol Res 2007; 35:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/7\">",
"      Pak CY, Poindexter JR, Peterson RD, et al. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 2002; 60:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/8\">",
"      Yu TF. Urolithiasis in hyperuricemia and gout. J Urol 1981; 126:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/9\">",
"      Falls WF Jr. Comparison of urinary acidification and ammonium excretion in normal and gouty subjects. Metabolism 1972; 21:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/10\">",
"      Seegmiller JE. Xanthine stone formation. Am J Med 1968; 45:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/11\">",
"      Riese RJ, Sakhaee K. Uric acid nephrolithiasis: pathogenesis and treatment. J Urol 1992; 148:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/12\">",
"      Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/13\">",
"      Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002; 40:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/14\">",
"      Kramer HJ, Choi HK, Atkinson K, et al. The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int 2003; 64:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/15\">",
"      Sperling O. Hereditary renal hypouricemia. Mol Genet Metab 2006; 89:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/16\">",
"      Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 2003; 63:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/17\">",
"      Abate N, Chandalia M, Cabo-Chan AV Jr, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004; 65:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/18\">",
"      Cameron MA, Maalouf NM, Adams-Huet B, et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006; 17:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/19\">",
"      Pak CY, Sakhaee K, Moe O, et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology 2003; 61:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/20\">",
"      Meydan N, Barutca S, Caliskan S, Camsari T. Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 2003; 37:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/21\">",
"      Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 2005; 20:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/22\">",
"      Daudon M, Traxer O, Conort P, et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 2006; 17:2026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/23\">",
"      Maalouf NM, Cameron MA, Moe OW, et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/24\">",
"      Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis 2006; 48:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/25\">",
"      Maalouf NM, Sakhaee K, Parks JH, et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004; 65:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/26\">",
"      Shekarriz B, Stoller ML. Uric acid nephrolithiasis: current concepts and controversies. J Urol 2002; 168:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/27\">",
"      Teichman JM. Clinical practice. Acute renal colic from ureteral calculus. N Engl J Med 2004; 350:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/28\">",
"      Matlaga BR, Kawamoto S, Fishman E. Dual source computed tomography: a novel technique to determine stone composition. Urology 2008; 72:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/29\">",
"      Asplin JR. Uric acid stones. Semin Nephrol 1996; 16:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/30\">",
"      Pak CY, Sakhaee K, Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 1986; 30:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/31\">",
"      Trinchieri A, Esposito N, Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Arch Ital Urol Androl 2009; 81:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/32\">",
"      Rodman JS. Prophylaxis of uric acid stones with alternate day doses of alkaline potassium salts. J Urol 1991; 145:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/33\">",
"      Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996; 155:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/34\">",
"      Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/62/3047/abstract/35\">",
"      Becker MA, Kisicki J, Khosravan R, et al. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers. Nucleosides Nucleotides Nucleic Acids 2004; 23:1111.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7378 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-110.137.129.113-46D95CF9A3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3047=[""].join("\n");
var outline_f2_62_3047=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6582391\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H327386715\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREDISPOSING CLINICAL CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12509811\">",
"      Gout",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H74756171\">",
"      - Increased fractional excretion of uric acid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H74756126\">",
"      Uric acid overproduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12509827\">",
"      Chronic diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12509834\">",
"      Diabetes mellitus and metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Urinary alkalinization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14770579\">",
"      Increased fluid intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Xanthine oxidase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6582391\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7378\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7378|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/49/5916\" title=\"table 1\">",
"      Secondary uricemia production",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/24/1416?source=related_link\">",
"      Asymptomatic hyperuricemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=related_link\">",
"      Clinical manifestations and diagnosis of gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29033?source=related_link\">",
"      Evaluation of the adult patient with established nephrolithiasis and treatment if stone composition is unknown",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=related_link\">",
"      General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7177?source=related_link\">",
"      Hypouricemia: Causes and clinical significance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/53/28499?source=related_link\">",
"      Patient information: Kidney stones in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/26/36266?source=related_link\">",
"      Prevention of recurrent gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=related_link\">",
"      Uric acid balance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_62_3048="Pamidronate: Drug information";
var content_f2_62_3048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pamidronate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?43/10/44196?source=see_link\">",
"    see \"Pamidronate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/54/39781?source=see_link\">",
"    see \"Pamidronate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F14289212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Review of Long-term Bisphosphonate Efficacy for Osteoporosis",
"     </span>",
"     <span class=\"collapsible-date\">",
"      May 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       In response to serious postmarketing adverse reactions, including atypical femur fractures, osteonecrosis of the jaw, and esophageal cancer, and a paucity of long-term efficacy data, the FDA conducted a systematic review of long-term bisphosphonate therapy for osteoporosis. To date, randomized controlled trials have shown that bisphosphonate therapy is effective in preventing fractures in trials of 3- to 4-years duration. Therefore, to examine long-term efficacy, three long-term extension trials (involving postmenopausal women) ranging in a duration of treatment from 6-10 years were used in the FDA&rsquo;s analysis. Based on the available long-term clinical trial data, the FDA was unable to identify subgroups of patients who are more likely to benefit from therapy beyond 3-5 years. Continuation of treatment should be based on individual assessment of risks, benefits, and preferences of patients and their physicians.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Until further data are available, the data suggests patients at low risk for fracture (eg, younger patients without a fracture history and bone mineral density [BMD] approaching normal) may be good candidates for discontinuation of therapy after 3-5 years. Patients at increased risk, such as older patients with a history of fracture and a BMD in the osteoporotic range, may benefit from continued therapy.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further investigation into the risks and benefits of long-term therapy, the usefulness of markers of bone turnover or BMD in determining duration or interruption of therapy, and surveillance or fracture risk after therapy discontinuation are needed.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For additional information, please refer to file://www.nejm.org/doi/pdf/10.1056/NEJMp1202619.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F205911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aredia&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F205912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aredia&reg;;",
"     </li>",
"     <li>",
"      Pamidronate Disodium Omega;",
"     </li>",
"     <li>",
"      Pamidronate Disodium&reg;;",
"     </li>",
"     <li>",
"      PMS-Pamidronate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F205952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote;",
"     </li>",
"     <li>",
"      Bisphosphonate Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F205914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Single doses should not exceed 90 mg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypercalcemia of malignancy:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Moderate cancer-related hypercalcemia (corrected serum calcium: 12-13.5 mg/dL):",
"     </i>",
"     60-90 mg, as a single dose over 2-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Severe cancer-related hypercalcemia (corrected serum calcium: &gt;13.5 mg/dL):",
"     </i>",
"     90 mg, as a single dose over 2-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Retreatment in patients who show an initial complete or partial response (allow at least 7 days to elapse prior to retreatment):",
"     </i>",
"     May retreat at the same dose if serum calcium does not return to normal or does not remain normal after initial treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Multiple myeloma, osteolytic bone lesions:",
"     </b>",
"     I.V.: 90 mg over 4 hours monthly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Lytic disease: American Society of Clinical Oncology (ASCO) guidelines:",
"     </i>",
"     90 mg over at least 2 hours every 3-4 weeks for 2 years; discontinue after 2 years in patients with responsive and/or stable disease; resume therapy with new-onset skeletal-related events (Kyle, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Newly-diagnosed, symptomatic (unlabeled dose):",
"     </i>",
"     30 mg over 2.5 hours monthly for at least 3 years (Gimsing, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Breast cancer, osteolytic bone metastases:",
"     </b>",
"     I.V.: 90 mg over 2 hours every 3-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Paget's disease (moderate-to-severe):",
"     </b>",
"     I.V.: 30 mg over 4 hours daily for 3 consecutive days (total dose = 90 mg); may retreat at initial dose if clinically indicated",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of androgen deprivation-induced osteoporosis (unlabeled use):",
"     </b>",
"     I.V.: 60 mg over 2 hours every 3 months (Smith, 2001)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F205915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Begin at lower end of adult dosing range.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F205916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Patients with serum creatinine &gt;3 mg/dL were excluded from clinical trials; there are only limited pharmacokinetic data in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Manufacturer recommends the following guidelines:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Treatment of bone metastases: Use is not recommended in patients with severe renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal impairment in indications other than bone metastases: Use clinical judgment to determine if benefits outweigh potential risks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Multiple myeloma: American Society of Clinical Oncology (ASCO) guidelines (Kyle, 2007):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe renal impairment (serum creatinine &gt;3 mg/dL",
"     <b>",
"      or",
"     </b>",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute) and extensive bone disease: 90 mg over 4-6 hours. However, a reduced initial dose should be considered if renal impairment was pre-existing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Albuminuria &gt;500 mg/24 hours (unexplained): Withhold dose until returns to baseline, then  recheck every 3-4 weeks; consider reinitiating at a dose not to exceed 90 mg every 4 weeks and with a longer infusion time of at least 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal toxicity:",
"     </b>",
"     In patients with bone metastases, treatment should be withheld for deterioration in renal function (increase of serum creatinine &ge;0.5 mg/dL in patients with normal baseline or &ge;1.0 mg/dL in patients with abnormal baseline). Resumption of therapy may be considered when serum creatinine returns to within 10% of baseline.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F5697666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary in patients with mild-to-moderate hepatic impairment; not studied in patients with severe hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F205888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as disodium: 30 mg, 90 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aredia&reg;: 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as disodium: 3 mg/mL (10 mL); 6 mg/mL (10 mL); 9 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as disodium [preservative free]: 3 mg/mL (10 mL); 9 mg/mL (10 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F205873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F205892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     I.V.: Infusion rate varies by indication. Longer infusion times (&gt;2 hours) may reduce the risk for renal toxicity, especially in patients with pre-existing renal insufficiency. The manufacturer recommends infusing over 2-24 hours for hypercalcemia of malignancy; over 2 hours for osteolytic bone lesions with metastatic breast cancer; and over 4 hours for Paget&rsquo;s disease and for osteolytic bone lesions with multiple myeloma. The ASCO guidelines for bisphosphonate use in multiple myeloma recommend infusing pamidronate over at least 2 hours; if therapy is withheld due to renal toxicity, infuse over at least 4 hours upon reintroduction of treatment after renal recovery (Kyle, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F205960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with calcium-containing infusion solutions such as Ringer's injection.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F205891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderate or severe hypercalcemia associated with malignancy (in conjunction with adequate hydration) with or without bone metastases; treatment of osteolytic bone lesions associated with multiple myeloma or metastatic breast cancer; moderate-to-severe Paget's disease of bone",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F2233145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of osteogenesis imperfecta; treatment of symptomatic bone metastases of thyroid cancer; prevention of bone loss associated with androgen deprivation treatment in prostate cancer",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F205962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Aredia&reg; may be confused with Adriamycin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Pamidronate may be confused with papaverine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F205950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Actual percentages may vary by indication; treatment for multiple myeloma is associated with higher percentage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (18% to 39%; transient), fatigue (&le;37%), headache (&le;26%), insomnia (&le;22%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypophosphatemia (&le;18%), hypokalemia (4% to 18%), hypomagnesemia (4% to 12%), hypocalcemia (&le;12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (&le;54%), vomiting (&le;36%), anorexia (&le;26%), abdominal pain (&le;23%), dyspepsia (&le;23%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection (&le;19%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia (&le;43%), granulocytopenia (&le;20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Infusion site reaction (&le;18%; includes induration, pain, redness and swelling)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia (&le;26%), weakness (&le;22%), arthralgia (&le;14%), osteonecrosis of the jaw (cancer patients: 1% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Serum creatinine increased (&le;19%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Dyspnea (&le;30%), cough (&le;26%), upper respiratory tract infection (&le;24%), sinusitis (&le;16%), pleural effusion (&le;11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Atrial fibrillation (&le;6%), hypertension (&le;6%), syncope (&le;6%), tachycardia (&le;6%), atrial flutter (&le;1%), cardiac failure (&le;1%), edema (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Somnolence (&le;6%), psychosis (&le;4%), seizure (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypothyroidism (&le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Constipation (&le;6%), gastrointestinal hemorrhage (&le;6%), diarrhea (&le;1%), stomatitis (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Leukopenia (&le;4%), neutropenia (&le;1%), thrombocytopenia (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, bone pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Uremia (&le;4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rales (&le;6%), rhinitis (&le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Moniliasis (&le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Acute renal failure, adult respiratory distress syndrome, allergic reaction, anaphylactic shock, angioedema, bone/joint/muscle pain (severe and occasionally incapacitating), bronchospasm, CHF, confusion, conjunctivitis, electrolyte/mineral abnormality, episcleritis, femoral fractures (atypical subtrochanteric, diaphyseal femoral), fluid overload, flu-like syndrome, focal segmental glomerulosclerosis (including collapsing variant), glomerulonephropathies, hallucinations (visual), hematuria, herpes virus reactivation, hyperkalemia, hypernatremia, hypotension, injection site phlebitis/thrombophlebitis, interstitial pneumonitis, iridocyclitis, iritis, joint and/or muscle pain (sometimes severe and/or incapacitating), left ventricular failure, lymphocytopenia, malaise, nephrotic syndrome, orbital inflammation, osteonecrosis (other than jaw), paresthesia, pruritus, rash, renal deterioration, renal failure, renal tubular disorders, scleritis, tetany, tubulointerstitial nephritis, uveitis, xanthopsia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F205895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pamidronate, other bisphosphonates, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F205877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone fractures: Atypical femur fractures (after minimal or no trauma) have been reported. The fractures include subtrochanteric femur (bone just below the hip joint) and diaphyseal femur (long segment of the thigh bone). Some patients experience prodromal pain weeks or months before the fracture occurs. It is unclear if bisphosphonate therapy is the cause for these fractures. Patients receiving long-term (&gt;3-5 years) bisphosphonate therapy may be at an increased risk. Consider discontinuing pamidronate in patients with a suspected femoral shaft fracture. Patients who present with thigh or groin pain in the absence of trauma should be evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Musculoskeletal pain: Infrequently, severe (and occasionally debilitating) bone, joint, and/or muscle pain have been reported during bisphosphonate treatment. The onset of pain ranged from a single day to several months. Consider discontinuing therapy in patients who experience severe symptoms; symptoms usually resolve upon discontinuation. Some patients experienced recurrence when rechallenged with same drug or another bisphosphonate; avoid use in patients with a history of these symptoms in association with bisphosphonate therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte abnormalities: Use has been associated with asymptomatic electrolyte abnormalities (including hypophosphatemia, hypokalemia, hypomagnesemia, and hypocalcemia). Rare cases of symptomatic hypocalcemia, including tetany,  have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myelosuppression: Patients with pre-existing anemia, leukopenia, or thrombocytopenia should be closely monitored during the first 2 weeks of treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Osteonecrosis of the jaw (ONJ): ONJ has been reported in patients receiving bisphosphonates. Risk factors include invasive dental procedures (eg, tooth extraction, dental implants, boney surgery); a diagnosis of cancer, with concomitant chemotherapy, radiotherapy, or corticosteroids; poor oral hygiene, ill-fitting dentures; and comorbid disorders (anemia, coagulopathy, infection, pre-existing dental disease). Most reported cases occurred after I.V. bisphosphonate therapy; however, cases have been reported following oral therapy. A dental exam and preventative dentistry should be performed prior to placing patients with risk factors on chronic bisphosphonate therapy. There is no evidence that discontinuing therapy reduces the risk of developing ONJ (Assael, 2009). The benefit/risk must be assessed by the treating physician and/or dentist/surgeon prior to any invasive dental procedure. Patients developing ONJ while on bisphosphonates should receive care by an oral surgeon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal deterioration: Single pamidronate doses should not exceed 90 mg. Initial or single doses have been associated with renal deterioration, progressing to renal failure and dialysis. Glomerulosclerosis (focal segmental) with or without nephrotic syndrome has also been reported. Longer infusion times (&gt;2 hours) may reduce the risk for renal toxicity, especially in patients with pre-existing renal insufficiency. Withhold pamidronate treatment (until renal function returns to baseline) in patients with evidence of renal deterioration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypercalcemia of malignancy (HCM): Adequate hydration is required during treatment (urine output ~2 L/day); avoid overhydration, especially in patients with heart failure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoparathyroidism: Use caution with a history of thyroid surgery; patients may have relative hypoparathyroidism, predisposing them to pamidronate-related hypocalcemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Multiple myeloma: According to the American Society of Clinical Oncology (ASCO) guidelines for bisphosphonates in multiple myeloma, treatment with pamidronate is not recommended for asymptomatic (smoldering) or indolent myeloma or with solitary plasmacytoma (Kyle, 2007).  The National Comprehensive Cancer Network&reg; (NCCN) multiple myeloma guidelines (v.1.2012) also do not recommend pamidronate use in stage 1 or smoldering disease, unless part of a clinical trial. Patients with Bence-Jones proteinuria and dehydration should be adequately hydrated prior to therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Patients with serum creatinine &gt;3 mg/dL were not studied in clinical trials; limited data are available in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute. Evaluate serum creatinine prior to each treatment. For the treatment of bone metastases, use is not recommended in patients with severe renal impairment. With indications other than bone metastases, use clinical judgment to determine if benefits outweigh potential risks in patients with renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F205882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: May enhance the hypocalcemic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Bisphosphonate Derivatives may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Bisphosphonate Derivatives may enhance the hypocalcemic effect of Phosphate Supplements.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Proton Pump Inhibitors: May diminish the therapeutic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SUNItinib: Bisphosphonate Derivatives may enhance the adverse/toxic effect of SUNItinib. Specifically, the risk of osteonecrosis of the jaw may be increased.  Management: Monitor for development of osteonecrosis of the jaw in patients receiving sunitinib and bisphosphonates.  Avoid invasive dental procedures if possible.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thalidomide: May enhance the nephrotoxic effect of Pamidronate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F205884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F205897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pamidronate has been shown to cross the placenta and cause adverse effects in animal reproduction studies. Bisphosphonates are expected to cross the human placenta. Bisphosphonates are incorporated into the bone matrix and gradually released over time. Theoretically, there may be a risk of fetal harm when pregnancy follows the completion of therapy. Based on limited case reports, serum calcium levels in the newborn may be transiently altered if pamidronate is administered during pregnancy; shortened gestational age and low birth weight have also been noted, but significant fetal toxicity has not been observed. Women of childbearing potential should be advised to avoid becoming pregnant during therapy. Monitoring of calcium concentrations in the mother during pregnancy and in the neonate after birth are recommended if therapy is required (Stathopoulos, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F205922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14699812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Breast-feeding is not recommended by the manufacturer. Pamidronate was not detected in the milk of a nursing woman (~6 months postpartum) receiving pamidronate 30 mg I.V. monthly. Following the first infusion, milk was pumped and collected for 0-24 hours and 25-48 hours, and each day pooled for analysis. Pamidronate readings were below the limit of quantification (&lt;0.4 micromole/L). During therapy, breast milk was pumped and discarded for the first 48 hours following each infusion prior to resuming nursing. The infant was breast-fed &gt;80% of the time; adverse events were not observed in the nursing infant (Simonoski, 2000). In a second case report, asymptomatic hypocalcemia was noted in a 2-month old breast-fed child. Hypocalcemia or hypoglycemia was not noted at birth (39 weeks gestation). The mother had been treated with pamidronate and alendronate for 1 year prior to conception. At 5 months of age, calcium and bone x-rays were normal (Hassen-Zrour, 2010). Monitoring the serum calcium concentrations of nursing infants is recommended (Stathopoulos, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F5697667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Multiple myeloma or metastatic bone lesions from solid tumors or Paget&rsquo;s disease: Take adequate daily calcium and vitamin D supplement (if patient is not hypercalcemic).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Pamidronate Disodium Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6 mg/mL (10 mL): $33.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Pamidronate Disodium Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg (1): $48.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     90 mg (1): $144.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F205886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum creatinine (prior to each treatment); serum electrolytes, including calcium, phosphate, magnesium, and potassium; CBC with differential; monitor for hypocalcemia for at least 2 weeks after therapy; dental exam and preventative dentistry prior to therapy for patients at risk of osteonecrosis, including all cancer patients; patients with pre-existing anemia, leukopenia, or thrombocytopenia should be closely monitored during the first 2 weeks of treatment; in addition, monitor urine albumin every 3-6 months in multiple myeloma patients",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F205889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Calcium (total): Adults: 9.0-11.0 mg/dL (SI: 2.05-2.54 mmol/L), may slightly decrease with aging; Phosphorus: 2.5-4.5 mg/dL (SI: 0.81-1.45 mmol/L)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F205898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aminomux (AR, PY, UY, VE);",
"     </li>",
"     <li>",
"      Aredia (AE, AT, AU, BB, BE, BF, BG, BH, BJ, BM, BR, BS, BZ, CH, CI, CL, CN, CO, CY, CZ, DE, DK, EE, EG, ET, FI, FR, GB, GH, GM, GN, GR, GY, HK, HN, HR, HU, ID, IE, IL, IN, IQ, IR, IT, JM, JO, JP, KE, KW, LB, LR, LU, LY, MA, ML, MR, MT, MU, MW, NE, NG, NL, NO, OM, PE, PH, PK, PL, PT, QA, RU, SA, SC, SD, SE, SG, SK, SL, SN, SR, SY, TH, TN, TR, TT, TW, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Pamisol (AU, MX, MY, NZ, SG);",
"     </li>",
"     <li>",
"      Panolin (KP);",
"     </li>",
"     <li>",
"      Panorin (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F205876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nitrogen-containing bisphosphonate; inhibits bone resorption and decreases mineralization by disrupting osteoclast activity (Gralow, 2009; Rogers, 2011)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F205894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hypercalcemia of malignancy (HCM): &le;24 hours for decrease in albumin-corrected serum calcium; maximum effect: &le;7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Paget&rsquo;s disease: ~1 month for &ge;50% decrease in serum alkaline phosphatase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: HCM: 7-14 days; Paget&rsquo;s disease: 1-372 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Poor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Not metabolized",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 21-35 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Biphasic; urine (30% to 62% as unchanged drug; lower in patients with renal dysfunction) within 120 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Dental Association Council on Scientific Affairs, &ldquo;Dental Management of Patients Receiving Oral Bisphosphonate Therapy,&rdquo;",
"      <i>",
"       JADA",
"      </i>",
"      , 2006, 137(8):1144-50. Available at file://jada.ada.org/cgi/content/full/137/8/1144",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/16873332/pubmed\" id=\"16873332\" target=\"_blank\">",
"        16873332",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Assael LA, &ldquo;Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2009, 67(5 Suppl):35-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/19371813/pubmed\" id=\"19371813\" target=\"_blank\">",
"        19371813",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bamias A, Kastritis E, Bamia C, et al, &ldquo;Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2005, 23(34):8580-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/16314620/pubmed\" id=\"16314620\" target=\"_blank\">",
"        16314620",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Diamond TH, Winters J, Smith A, et al, &ldquo;The Antiosteoporotic Efficacy of Intravenous Pamidronate in Men With Prostate Carcinoma Receiving Combined Androgen Blockade: A Double Blind, Randomized, Placebo-Controlled Crossover Study,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 2001, 92(6):1444-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/11745221/pubmed\" id=\"11745221\" target=\"_blank\">",
"        11745221",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Durie BG, Katz M, and Crowley J, &ldquo;Osteonecrosis of the Jaw and Bisphosphonate,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2005, 353(1):99-102.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/16000365/pubmed\" id=\"16000365\" target=\"_blank\">",
"        16000365",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fitton A and McTavish D, &ldquo;Pamidronate: A Review of Its Pharmacological Properties and Therapeutic Efficacy in Resorptive Bone Disease,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1991, 41(2):289-318.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/1709854/pubmed\" id=\"1709854\" target=\"_blank\">",
"        1709854",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      French AE, Kaplan N, Lishner M, et al, &ldquo;Taking Bisphosphonates During Pregnancy,&rdquo;",
"      <i>",
"       Can Fam Physician",
"      </i>",
"      , 2003, 49:1281-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/14594094/pubmed\" id=\"14594094\" target=\"_blank\">",
"        14594094",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gimsing P, Carlson K, Turesson I, et al, &ldquo;Effect of Pamidronate 30 mg Versus 90 mg on Physical Function in Patients With Newly Diagnosed Multiple Myeloma (Nordic Myeloma Study Group): A Double-Blind, Randomised Controlled Trial,&rdquo;",
"      <i>",
"       Lancet Oncol",
"      </i>",
"      , 2010, 11(10):973-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/20863761/pubmed\" id=\"20863761\" target=\"_blank\">",
"        20863761",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Glorieux FH, Bishop NH, Plotkin H, et al, &ldquo;Cyclic Administration of Pamidronate in Children With Severe Osteogenesis Imperfecta,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 339(14):947-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/9753709/pubmed\" id=\"9753709\" target=\"_blank\">",
"        9753709",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gralow JR, Biermann JS, Farooki A, et al, &ldquo;NCCN Task Force Report: Bone Health in Cancer Care,&rdquo;",
"      <i>",
"       J Natl Compr Canc Netw",
"      </i>",
"      , 2009, 7(Suppl 3):1-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/19555589/pubmed\" id=\"19555589\" target=\"_blank\">",
"        19555589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hassen-Zrour S, Korb&acirc;a W, B&eacute;jia I, et al, \"Maternal and Fetal Outcome After Long-Term Bisphosphonate Exposure Before Conception,\"",
"      <i>",
"       Osteoporos Int",
"      </i>",
"      , 2010, 21(4):709-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/19533208/pubmed\" id=\"19533208\" target=\"_blank\">",
"        19533208",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hillner BE, Ingel JN, Chlebowski RT, et al, &ldquo;American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2003, 21(21):4042-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/12963702/pubmed\" id=\"12963702\" target=\"_blank\">",
"        12963702",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kellihan MJ and Mangino PD, &ldquo;Pamidronate,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1992, 26(10):1262-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/1421653/pubmed\" id=\"1421653\" target=\"_blank\">",
"        1421653",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kyle RA, Yee GC, Somerfield MR, et al, &ldquo;American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2007, 25(17):2464-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/17515569/pubmed\" id=\"17515569\" target=\"_blank\">",
"        17515569",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lteif AN and Zimmerman D, &ldquo;Bisphosphonates for Treatment of Childhood Hypercalcemia,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1998, 102(4 Pt 1):990-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/9755274/pubmed\" id=\"9755274\" target=\"_blank\">",
"        9755274",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Maerevoet M, Martin C, and Duck L, &ldquo;Osteonecrosis of the Jaw and Bisphosphonates,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2005, 353(1):99-102.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/16003838/pubmed\" id=\"16003838\" target=\"_blank\">",
"        16003838",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Major P, Lortholary A, Hon J, et al, \"Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2001, 19(2):558-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/11208851/pubmed\" id=\"11208851\" target=\"_blank\">",
"        11208851",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McMahon RE, Bouquot JE, Glueck CJ, et al, &ldquo;Osteonecrosis: A Multifactorial Etiology,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2004, 62(7):904-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/15244000/pubmed\" id=\"15244000\" target=\"_blank\">",
"        15244000",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Multiple Myeloma,&rdquo; Version 1.2012. Available at  file://www.nccn.org/professionals/physician_gls/PDF/myeloma.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ralston SH, Gallacher SJ, Patel U, et al, &ldquo;Cancer-Associated Hypercalcemia: Morbidity and Mortality, Clinical Experience in 126 Treated Patients,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1990, 112(7):499-504.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/2138442/pubmed\" id=\"2138442\" target=\"_blank\">",
"        2138442",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rauch F and Glorieux FH, &ldquo;Osteogenesis Imperfecta,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2004, 363(9418):1377-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/15110498/pubmed\" id=\"15110498\" target=\"_blank\">",
"        15110498",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rogers MJ, Crockett JC, Coxon FP, et al, &ldquo;Biochemical and Molecular Mechanisms of Action of Bisphosphonates,&rdquo;",
"      <i>",
"       Bone",
"      </i>",
"      , 2011, 49(1):34-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/21111853/pubmed\" id=\"21111853\" target=\"_blank\">",
"        21111853",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ruggiero SL, Dodson TB, Assael LA, et al, &ldquo;American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws-2009 Update,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2009, 67(5 Suppl):2-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/19371809/pubmed\" id=\"19371809\" target=\"_blank\">",
"        19371809",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Siminoski K, Fitzgerald AA, Flesch G, et al, \"Intravenous Pamidronate for Treatment of Reflex Sympathetic Dystrophy During Breast Feeding,\"",
"      <i>",
"       J Bone Miner Res",
"      </i>",
"      , 2000, 15(10):2052-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/11028460/pubmed\" id=\"11028460\" target=\"_blank\">",
"        11028460",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith MR, McGovern FJ, Zietman AL, et al, &ldquo;Pamidronate to Prevent Bone Loss During Androgen-Deprivation Therapy For Prostate Cancer,&rdquo;",
"      <i>",
"       N Engl J Med,",
"      </i>",
"      2001, 345(13):948-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/11575286/pubmed\" id=\"11575286\" target=\"_blank\">",
"        11575286",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stathopoulos IP, Liakou CG, Katsalira A, et al, \"The Use of Bisphosphonates in Women Prior to or During Pregnancy and Lactation,\"",
"      <i>",
"       Hormones (Athens)",
"      </i>",
"      , 2011, 10(4):280-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/22281884/pubmed\" id=\"22281884\" target=\"_blank\">",
"        22281884",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steelman J and Zeitler P, &ldquo;Treatment of Symptomatic Pediatric Osteoporosis With Cyclic Single-Day Intravenous Pamidronate Infusions,,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2003, 142(4):417-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/12712060/pubmed\" id=\"12712060\" target=\"_blank\">",
"        12712060",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tarassoff P and Csermak K, &ldquo;Avascular Necrosis of the Jaws: Risk Factors in Metastatic Cancer Patients,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2003, 61(10):1238-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/14586868/pubmed\" id=\"14586868\" target=\"_blank\">",
"        14586868",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vitale G, Fonderico F, Martignetti A, et al, &ldquo;Pamidronate Improves the Quality of Life and Induces Clinical Remission of Bone Metastases in Patients With Thyroid Cancer,&rdquo;",
"      <i>",
"       Br J Cancer",
"      </i>",
"      , 2001, 84(12):1586-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/11401309/pubmed\" id=\"11401309\" target=\"_blank\">",
"        11401309",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Van Poznak CH, Temin S, Yee GC, et al, &ldquo;American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2011, 29(9):1221-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/62/3048/abstract-text/21343561/pubmed\" id=\"21343561\" target=\"_blank\">",
"        21343561",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9736 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-D70169F40B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3048=[""].join("\n");
var outline_f2_62_3048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14289212\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205911\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205912\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205952\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205914\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205915\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205916\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5697666\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205888\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205873\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205892\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205960\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205891\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2233145\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205962\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205950\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205895\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205877\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299814\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205882\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205884\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205897\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205922\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14699812\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5697667\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323599\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205886\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205889\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205898\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205876\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205894\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9736\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9736|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?43/10/44196?source=related_link\">",
"      Pamidronate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/54/39781?source=related_link\">",
"      Pamidronate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_62_3049="FTT growth trajectory";
var content_f2_62_3049=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Typical growth trajectory in children with undernutrition",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 537px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The typical growth trajectory for children with undernutrition demonstrates normal growth parameters at birth, followed by deceleration in weight (as depicted above), and finally deceleration in length.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: The National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000). Available at www.cdc.gov/growthcharts.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3049=[""].join("\n");
var outline_f2_62_3049=null;
var title_f2_62_3050="BL starry-sky pattern";
var content_f2_62_3050=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Burkitt lymphoma &ldquo;starry-sky&rdquo; pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low-power magnification showing sheets of uniform neoplastic cells with evenly interspersed reactive tingible-body macrophages resulting in characteristic \"starry-sky\" pattern. Hematoxylin-eosin stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ioachim HL, Medeiros LJ. Burkitt lymphoma. In: Ioachim's Lymph Node Pathology, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3050=[""].join("\n");
var outline_f2_62_3050=null;
var title_f2_62_3051="Lab tests in severe OHSS";
var content_f2_62_3051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory monitoring in women with grade 3 OHSS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukocyte count",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemoglobin and hematocrit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrolytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Once, repeat as indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver function tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prothrombin and partial thromboplastin time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest radiograph (if respiratory symptoms are present)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3051=[""].join("\n");
var outline_f2_62_3051=null;
var title_f2_62_3052="Reducing the supply of fibril precursors in systemic amyloidosis";
var content_f2_62_3052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F87769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F87769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Reducing the supply of fibril precursors in systemic amyloidosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Aim of treatment",
"       </td>",
"       <td class=\"subtitle1\">",
"        Example of treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AA amyloidosis",
"       </td>",
"       <td>",
"        Suppress the acute phase response and thereby reduce the production of serum amyloid A protein",
"       </td>",
"       <td>",
"        <p>",
"         Antiinflammatory and immunosuppressive therapy in patients with rheumatoid arthritis and Crohn's disease (eg, anti-TNF antibodies)",
"        </p>",
"        <p>",
"         Colchicine for patients with familial Mediterranean fever",
"        </p>",
"        Surgery for patients with osteomyelitis and rare cytokine-producing tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AL amyloidosis",
"       </td>",
"       <td>",
"        Suppress production of monoclonal immunoglobulin light chains",
"       </td>",
"       <td>",
"        Chemotherapy directed at plasma cell dyscrasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hereditary amyloidosis",
"       </td>",
"       <td>",
"        Eliminate source of genetically variant protein",
"       </td>",
"       <td>",
"        Orthotopic liver transplantation for patients with familial amyloid polyneuropathy secondary to variant transthyretin or renal amyloidosis secondary to variant fibrinogen A &alpha;-chain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &beta;",
"        <sub>",
"         2",
"        </sub>",
"        -microglobulin amyloidosis",
"       </td>",
"       <td>",
"        Reduce plasma concentration of &beta;",
"        <sub>",
"         2",
"        </sub>",
"        -microglobulin",
"       </td>",
"       <td>",
"        Renal transplantation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted by permission from: Macmillan Publishers Ltd: Nature Clinical Practice Nephrology. Gillmore JD, Hawkins PN. Drug insight: Emerging therapies for amyloidosis. Nat Clin Pract Nephrol 2006; 2:263. Copyright &copy; 2006.",
"     <a href=\"file://www.nature.com/nrneph\" style=\"FONT-STYLE: italic\" target=\"_blank\">",
"      www.nature.com/nrneph",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3052=[""].join("\n");
var outline_f2_62_3052=null;
var title_f2_62_3053="Longitudinal recovery in MRI";
var content_f2_62_3053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 502px\">",
"   <div class=\"ttl\">",
"    Rate of recovery during longitudinal relaxation in MRI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 482px; height: 244px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Recovery of the longitudinal component of magnetization to its equilibrium value is exponential with a time constant T",
"    <sub>",
"     1",
"    </sub>",
"    . T",
"    <sub>",
"     1",
"    </sub>",
"    depends upon field strength, temperature, and tissue composition.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3053=[""].join("\n");
var outline_f2_62_3053=null;
var title_f2_62_3054="Aminoglycoside nomogram";
var content_f2_62_3054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62508&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62508&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Once-daily dosing nomogram for aminoglycosides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 308px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nomogram showing the relationship between serum gentamicin or tobramycin concentrations and time beginning at six hours after a single dose of 7 mg/kg. The interval for drug administration varied with estimated creatinine clearance (Ccr): every 24 hours at a Ccr &ge;60 mL/min; every 36 hours at a Ccr of 40 to 59 mL/min; and every 48 hours at a Ccr of 20 to 39 mL/min.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nicolau, D, Quintiliani, R, Nightingale, CH. Once-daily aminoglycosides. Conn Med 1992; 56:561. Copyright &copy; 1992 Connecticut State Medical Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3054=[""].join("\n");
var outline_f2_62_3054=null;
var title_f2_62_3055="Lateral view displaced transverse patella fracture";
var content_f2_62_3055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral view of displaced transverse patella fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 333px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the significant articular step-off (arrow) and fracture diastasis (arrowhead). This injury must be referred for orthopedic care.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jim Blount, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_62_3055=[""].join("\n");
var outline_f2_62_3055=null;
